Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
9 Results for "
Cyto c
" in MedChemExpress (MCE) Product Catalog:
Products (9)
9 Results for "Cyto c" in MCE Product Catalog:
1
1 Cited Publications
PETCM is an activator of caspase-3 and acts as an cytochrome c (cyto c)-dependent manner. PETCM promotes Apaf-1 oligomerization and induces cell apoptosis in HeLa cells .
Cat. No.: HY-N6017
CAS No.: 19906-72-0
Target:
Research Areas:
AKOS-22 is a potent mitochondrial protein VDAC1 (voltage-dependent anion channel 1) inhibitor (Kd=15.4 μM). AKOS-22 interacts with VDAC1 and inhibiting both VDAC1 oligomerization and apoptosis. AKOS-22 protects against mitochondrial dysfunction .
Cat. No.: HY-146197
CAS No.: 2490538-26-4
Apoptotic agent-1 (Compound 8a) is an apoptotic agent with high antiproliferative activity against cancer cells and low cytotoxic effect. Apoptotic agent-1 induces over-expression of Fas receptor and Cyto C genes .
Cat. No.: HY-111217R
CAS No.: 878983-38-1
Research Areas:
AKOS-22 (Standard) is the analytical standard of AKOS-22 (HY-111217). This product is intended for research and analytical applications. AKOS-22 is a potent mitochondrial protein VDAC1 (voltage-dependent anion channel 1) inhibitor (Kd=15.4 μM). AKOS-22 interacts with VDAC1 and inhibiting both VDAC1 oligomerization and apoptosis. AKOS-22 protects against mitochondrial dysfunction .
Cat. No.: HY-103349R
CAS No.: 10129-56-3
Target:
Research Areas:
PETCM (Standard) is the analytical standard of PETCM (HY-103349). This product is intended for research and analytical applications. PETCM is an activator of caspase-3 and acts as an cytochrome c (cyto c)-dependent manner. PETCM promotes Apaf-1 oligomerization and induces cell apoptosis in HeLa cells .
Cat. No.: HY-183366
Research Areas:
HDAC1-IN-14 is an indole-based benzamide selective HDAC1 inhibitor with an IC50 of 77 nM. HDAC1-IN-14 acts as an antiproliferative agent, with GI50 values ranging from nanomolar to low micromolar levels in various cancer cells. HDAC1-IN-14 induces G0-G1 cell cycle arrest in colon cancer cells. HDAC1-IN-14 upregulates the expression of Caspase-3, Cyto-C and Bax, and downregulates the expression of AKT-1. HDAC1-IN-14 can be used in research related to leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, prostate cancer and breast cancer .
Cat. No.: HY-P71040
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: SCO1; SCO (Cytochrome Oxidase Deficient, Yeast) Homolog 1; Prev. SCOD1; SCO Cytochrome Oxidase Deficient Homolog 1; SCO1, Cytochrome C Oxidase Assembly Protein; Protein SCO1 Homolog, Mitochondrial; SCO Cytochrome C Oxidase Assembly Protein 1; MC4DN4; Cyto
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
